What is LBRX's exchange offer (note 12)?

LBRX (LBRX) reported exchange offer (note 12) of $28.57M in Q4 2025.

What does exchange offer (note 12) mean?

Represents the non-cash impact of converting debt or preferred equity instruments into common stock. This metric is critical for understanding changes in the capital structure and the potential dilution effect on existing shareholders resulting from the settlement of financial obligations.

LBRX LBRX Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

MapLight Therapeutics, Inc. MPLT

$126.92M—

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$874.06M+163%

Enterprise value$556.86M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: LBRX’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's exchange offer (note 12)?: LBRX (LBRX) reported exchange offer (note 12) of $28.57M in Q4 2025.
What does exchange offer (note 12) mean?: Represents the non-cash impact of converting debt or preferred equity instruments into common stock. This metric is critical for understanding changes in the capital structure and the potential dilution effect on existing shareholders resulting from the settlement of financial obligations.